These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7579948)

  • 1. [An evaluation of a method for measuring apolipoproteins as a sensitive marker for estimating lipid metabolic disorder in a population at risk for essential arterial hypertension (EAH)].
    Azoicăi D; Ivan A; Gheorghiţă N; Stoica O; Hurjui J; Cărăuşu EM
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(1):41-5. PubMed ID: 7579948
    [No Abstract]   [Full Text] [Related]  

  • 2. [The evaluation of a method for determining apolipoproteins as a sensitive indicator in assessing lipid metabolic disorder in a population at risk for essential arterial hypertension (EAHT)].
    Azoicăi D; Ivan A; Gheorghiţă N; Pavel M; Jerca L; Iacobovici A; Ungureanu G; Stoica O; Hurjui J
    Rev Med Chir Soc Med Nat Iasi; 1995; 99(3-4):109-14. PubMed ID: 9455355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinico-epidemiological observations on the relation between determining the cardiovascular risk--behavioral, constitutional and metabolic--and essential arterial hypertension].
    Azoicăi D; Ivan A; Stoica O; Cărăuşu EM; Petrovanu R; Coman A; Gheorghiţă N; Brumă D
    Bacteriol Virusol Parazitol Epidemiol; 1995; 40(1):46-50. PubMed ID: 7579949
    [No Abstract]   [Full Text] [Related]  

  • 4. [The epidemiological and laboratory aspects of the risk factors for essential arterial hypertension in adults in a rural area].
    Azoicăi D; Ivan A; Grigorescu R; Groll M; Pisică-Donose G; Tataru M; Serban F; Busuioc A; Gheorghiţă N; Pavel M
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):44-51. PubMed ID: 9132111
    [No Abstract]   [Full Text] [Related]  

  • 5. Some risk factors for essential arterial hypertension. Comparative epidemiological investigations in industrial and school units.
    Ivan A; Groll M; Datcu MD; Duda R; Serban F; Busuioc A; Mitroi I; Georgescu G; Vieriu V; Azoicăi D
    Rev Med Chir Soc Med Nat Iasi; 1990; 94(2):345-50. PubMed ID: 2100847
    [No Abstract]   [Full Text] [Related]  

  • 6. [Screening-type epidemiological assessments in industrial units of various profiles for the prevalence of increases in arterial pressure values and for the carriers of risk factors for essential arterial hypertension].
    Azoicăi D; Ivan A; Silion I; Serban F; Groll M; Bunea C; Grigorescu R; Pisică-Donose G
    Bacteriol Virusol Parazitol Epidemiol; 1994; 39(1-2):57-62. PubMed ID: 7981529
    [No Abstract]   [Full Text] [Related]  

  • 7. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children.
    Ogawa Y; Kikuchi T; Nagasaki K; Hiura M; Tanaka Y; Uchiyama M
    Hypertens Res; 2005 Jan; 28(1):51-7. PubMed ID: 15969255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of lipid and glycaemic abnormalities in hypertensive patients: a retrospective survey.
    Joglekar SJ; Nanivadekar AS
    Indian Heart J; 1996; 48(4):371-4. PubMed ID: 8908824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum lipid disturbances, obesity and diabetes among 40-year-old inhabitants of the city and the province of Poznan with arterial hypertension and coronary heart disease in the context of the negative elements of health behaviour].
    Kara I
    Przegl Lek; 2005; 62 Suppl 3():51-4. PubMed ID: 16521920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
    Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
    Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated lipid abnormalities in rural and urban normotensive and hypertensive north-west Indians.
    Malhotra P; Kumari S; Singh S; Varma S
    J Assoc Physicians India; 2003 May; 51():459-63. PubMed ID: 12974426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of three-dimensional body scanner: observation of prevalence of metabolic syndrome.
    Lin JD; Chiou WK; Weng HF; Fang JT; Liu TH
    Clin Nutr; 2004 Dec; 23(6):1313-23. PubMed ID: 15556253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The Navarra study. Prevalence of arterial hypertension, hyperlipidemia and obesity in the infant-child population of Navarra. Association of risk factors].
    Elcarte López R; Villa Elizaga I; Sada Goñi J; Gasco Eguiluz M; Oyarzábal Irigoyen M; Sola Mateos A; Martínez González A; Elcarte López T; Ayensa Mezquiriz I; Castiella Lafuente F
    An Esp Pediatr; 1993 May; 38(5):428-36. PubMed ID: 8503586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of risk factors for essential arterial hypertension in industrial and school environments.
    Ivan A; Groll M; Hurjui J; Frasin G; Vieriu V; Chiriac V; Fătu C; Mitroi I
    Sante Publique (Bucur); 1990; 33(1):39-48. PubMed ID: 2218811
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
    Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
    Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk factors are really linked in the metabolic syndrome: this phenomenon suggests clustering rather than coincidence.
    Aizawa Y; Kamimura N; Watanabe H; Aizawa Y; Makiyama Y; Usuda Y; Watanabe T; Kurashina Y
    Int J Cardiol; 2006 May; 109(2):213-8. PubMed ID: 16023231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of lipid levels, hyperlipidemia prevalence and its risk factors between Guangxi Hei Yi Zhuang and Han populations.
    Yin R; Chen Y; Pan S; He F; Liu T; Yang D; Wu J; Yao L; Lin W; Li R; Huang J
    Arch Med Res; 2006 Aug; 37(6):787-93. PubMed ID: 16824940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.
    Martínez-Calatrava MJ; González-Sánchez JL; Zabena C; Martínez-Larrad MT; Luque-Otero M; Serrano-Ríos M
    J Hypertens; 2007 Apr; 25(4):773-7. PubMed ID: 17351368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidaemia and cardiovascular disease: apolipoprotein measurements and metabolic syndrome as predictors of cardiovascular risk.
    Deans KA; Dominiczak MH
    Curr Opin Lipidol; 2008 Dec; 19(6):624-6. PubMed ID: 18957887
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.